Literature DB >> 2614266

Quantitation of apoB-48 and apoB-100 by gel scanning or radio-iodination.

D B Zilversmit1, T M Shea.   

Abstract

In this presentation, we have validated two procedures for the separation and quantitation of apoB-48 and apoB-100 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE): 1) gamma counting of radio-iodinated lipoproteins and 2) scanning of stained gels. Total apoB in SDS solutions was determined by absorbance at 220 nm, and validated by amino acid analysis. The absorbance at 220 nm, in contrast to the Lowry procedure, could be used with BSA as a standard without correction factors. At relative apoB-48 concentrations higher than 10% of total apoB, both scanning and radio-iodination gave reliable results. At lower relative apoB-48 concentrations, the radio-iodine method appeared to be superior, but at low total apoB concentrations, the efficiency of radio-iodination was low.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2614266

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Quantification of apolipoprotein B-48 and B-100 in rat liver endoplasmic reticulum and Golgi fractions.

Authors:  I J Cartwright; J A Higgins
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

2.  Plasma PCSK9 correlates with apoB-48-containing triglyceride-rich lipoprotein production in men with insulin resistance.

Authors:  Jean-Philippe Drouin-Chartier; André J Tremblay; Jean-Charles Hogue; Valéry Lemelin; Benoît Lamarche; Patrick Couture
Journal:  J Lipid Res       Date:  2018-06-26       Impact factor: 5.922

3.  Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.

Authors:  Margaret R Diffenderfer; Margaret E Brousseau; John S Millar; P Hugh R Barrett; Chorthip Nartsupha; Peter M Schaefer; Megan L Wolfe; Gregory G Dolnikowski; Daniel J Rader; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

4.  Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta.

Authors:  L B Nielsen; S Stender; M Jauhiainen; B G Nordestgaard
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

5.  Lipid and apolipoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats.

Authors:  I J Martins; A J Sainsbury; J C Mamo; T G Redgrave
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

6.  Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans.

Authors:  B O Schneeman; L Kotite; K M Todd; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia.

Authors:  André J Tremblay; Benoît Lamarche; Jean-Charles Hogue; Patrick Couture
Journal:  J Lipid Res       Date:  2009-03-22       Impact factor: 5.922

8.  Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects.

Authors:  Esther M M Ooi; Alice H Lichtenstein; John S Millar; Margaret R Diffenderfer; Stefania Lamon-Fava; Helen Rasmussen; Francine K Welty; P Hugh R Barrett; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2012-07-06       Impact factor: 5.922

9.  The effect of Puerariae radix on lipoprotein metabolism in liver and intestinal cells.

Authors:  Jeong-Sook Lee; John Mamo; Nerissa Ho; Sebely Pal
Journal:  BMC Complement Altern Med       Date:  2002-12-16       Impact factor: 3.659

10.  The effect of 12 weeks of aerobic, resistance or combination exercise training on cardiovascular risk factors in the overweight and obese in a randomized trial.

Authors:  Suleen S Ho; Satvinder S Dhaliwal; Andrew P Hills; Sebely Pal
Journal:  BMC Public Health       Date:  2012-08-28       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.